The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost Thu, 28 Apr 2005 What does $4 billion dollars in drug advertising buy? The Washington Post reports that a University of Washington study published in the Journal of the American Medical Association confirms the insidious…
Zyprexa – Risperdal – Abilify – Clozari Kill Elderly Tue, 12 Apr 2005 The long-denied, hidden truth about the deadly risks of antipsychotic drugs is about to be disclosed to the public. The New York Times reports that the FDA will now require Black Box warnings about the increased risk…
UK Parliament Report Re: Pharma Influence / US RegulatorsComatose as 258 Fatal Suicides Linked to Neurontin Wed, 6 Apr 2005 The Health Committee of the British House of Commons, has just released its report, “The Influence of the Pharmaceutical Industry.” This landmark document is not just of value to UK…
Two Federal Courts Reject Pfizer’s Federal Preemption Argument in cases involving Zoloft Fri, 01 Apr 2005 With assistance from Daniel Troy as chief counsel of the FDA, Pfizer argued that state courts have no right to decide that a drug manufacturer can be held liable for not disclosing severe –…
Minnesota Attorney General Supports Widow in Zoloft Suicide Case Tue, 22 Mar 2005 A press release from the law firm, Baum Hedlund announces that Minnesota’s State Attorney General filed a legal brief refuting Pfizer’s claim that “it should be immune from liability for failing to warn about dangerous side effects…
NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ Sat, 5 Mar 2005 A group of dissident NIH scientists represented by an 18 member executive committee, are gripping about new rules prohibiting them from accepting fees for outside activities. Conflict of interest rules apply…
Pfizer Marketing Scheme Stirs Concern_NYT / Corporate Responsibility Movement Puts PhRMA on Notice_ ICCR Mon, 7 Mar 2005 The New York Times reports that Pfizer is planning to lock up the market for heart treaments by bundling its new drug (toretrapib, which is still in experimental stage of development) to…
FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT Thu, 17 Feb 200 A three day public advisory panel hearing which is overflowing with attendees from around the world, is an investigation of the conduct of pharmaceutical company giants and the FDA. The hearing began…
THE NEW YORK TIMES February 12, 2005 Drug Regulators Are Trying to Quash Study, Senator Says By GARDINER HARRIS WASHINGTON, Feb. 11 – The tension and intrigue surrounding a crucial federal drug advisory committee meeting next week, already high, reached a boil on Friday when Senator Charles E. Grassley charged…
NIH to Ban Consulting Deals With Drug Firms – LAT / NYT Tue, 1 Feb 2005 Thanks to the investigative reports by David Willman in the Los Angeles Times, shedding light on secret financial ties by sernior scientists at the National Instiutes of Health, the public gained insight into the…
Corporate Welfare Runs Amok – NYT Editorial Sun, 30 Jan 2005 The administration has gone another step toward doing away with corporate taxes – by offering a “tax holiday” to America’s richest multinationals. The 35% corporate tax rate is being winnowed down to the “puny rate” of 5.25% for corporations…
Bad Medicine: A Gift for Drug Makers–Malpractice Bill Shields Drugmakers Sat, 15 Jan 2005 Knowledgable critics – among them practicing physicians, health care analysts, medical journal editors, journalists, and lay citizens–have reached the conclusion that America’s for-profit health care system – which eats up 16% of the budget–has failed to…
